Consequently, the usage of inhibitors of the protein–protein interaction of MYC and NMYC with MAX is a possible treatment strategy for both neuroendocrine- and AC-derived colorectal cancer cell lines that harbor a subpopulation with potential stem-like properties. Here, MAX is linked to colorectal cancer.